These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9599067)

  • 1. From Hypertension to Heart Failure. Symposium proceedings. Stockholm, Sweden, January 1997.
    Scand Cardiovasc J Suppl; 1998; 47():1-80. PubMed ID: 9599067
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous milrinone: therapeutic responses in heart failure. Proceedings of a symposium. Stockholm, Sweden, September 19, 1990.
    Am Heart J; 1991 Jun; 121(6 Pt 2):1937-2000. PubMed ID: 2035422
    [No Abstract]   [Full Text] [Related]  

  • 3. Recent Advances in Angiotensin-Converting Enzyme Inhibition in the Treatment of Hypertension and Heart Failure. Symposium proceedings. Barcelona, Spain, August 30, 1992.
    Am J Cardiol; 1993 Jun; 71(17):1E-68E. PubMed ID: 8101035
    [No Abstract]   [Full Text] [Related]  

  • 4. Adrenergic receptors in hypertension and heart failure.
    Gavras H
    Am J Hypertens; 2004 Jan; 17(1):98-9. PubMed ID: 14700521
    [No Abstract]   [Full Text] [Related]  

  • 5. [ACE inhibitors in hypertension and heart failure].
    Riegger AJ
    Internist (Berl); 1992 Oct; 33(10):639-44. PubMed ID: 1428682
    [No Abstract]   [Full Text] [Related]  

  • 6. Symposium reporter 2003. New therapeutic options in the management of hypertension to heart failure. Orlando, Florida, USA, March 6, 2003.
    Cohn JN; Velazquez EJ; Musher J
    J Am Med Dir Assoc; 2003; ():1-16, quiz 17. PubMed ID: 12924409
    [No Abstract]   [Full Text] [Related]  

  • 7. A vascular protective concept in hypertension and heart failure. Proceedings of the 4th International Symposium on Cilazapril. Istanbul, Turkey, November 25-27, 1993.
    J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S1-99. PubMed ID: 7700059
    [No Abstract]   [Full Text] [Related]  

  • 8. A new angiotensin-converting enzyme inhibitor: treatment of hypertension and congestive heart failure. Proceedings of an international symposium on enalapril, sponsored by Merck Sharp & Dohme International, São Paulo, Brazil, November 10, 1984.
    Drugs; 1985; 30 Suppl 1():1-96. PubMed ID: 2994983
    [No Abstract]   [Full Text] [Related]  

  • 9. [The role of angiotensin converting enzyme inhibition for therapy of patients with hypertension and heart failure].
    Hoyen HA; Alpert JS
    Cardiology; 1993; 82 Suppl 1():3-19. PubMed ID: 8519018
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cardiovascular pharmacology (IX). Angiotensin-converting enzyme inhibitors in hypertension and heart failure].
    de Teresa E; Espinosa JS; Gómez Doblas JJ
    Rev Esp Cardiol; 1995 Feb; 48(2):128-41. PubMed ID: 7886264
    [No Abstract]   [Full Text] [Related]  

  • 11. Angiotensin receptor--neprilysin inhibiton (ARNI)--a novel therapeutic concept for management of hypertension and heart failure.
    Kjeldsen SE; Hedner T; Narkiewicz K; Oparil S
    Blood Press; 2012 Dec; 21(6):329-30. PubMed ID: 23210746
    [No Abstract]   [Full Text] [Related]  

  • 12. [Angiotensin-converting enzyme inhibition: a pathophysiologically based concept for the therapy of hypertension and heart failure].
    Stumpe KO; Overlack A; Kolloch R
    Dtsch Med Wochenschr; 1984 Aug; 109(34):1295-9. PubMed ID: 6088205
    [No Abstract]   [Full Text] [Related]  

  • 13. AT1-receptor blockers in hypertension and heart failure: clinical experience and future directions.
    Willenheimer R; Dahlöf B; Rydberg E; Erhardt L
    Eur Heart J; 1999 Jul; 20(14):997-1008. PubMed ID: 10381851
    [No Abstract]   [Full Text] [Related]  

  • 14. ACE-inhibition: state of the art. Symposium held during the Xth Congress of the European Society of Cardiology. Vienna, August 31, 1988. Proceedings.
    Cardiology; 1989; 76 Suppl 2():1-68. PubMed ID: 2766310
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diuretic therapy].
    Knauf H
    Internist (Berl); 1992 Nov; 33(11):W113-25. PubMed ID: 1478823
    [No Abstract]   [Full Text] [Related]  

  • 16. Symposium on the endocrinology of cardiac failure. Stockholm, Sweden, April 25-26, 1985.
    Acta Med Scand Suppl; 1986; 707():1-99. PubMed ID: 3461686
    [No Abstract]   [Full Text] [Related]  

  • 17. [Administration of captopril (aceten++, ++"Vokhardt"++) in hypertension and congestive heart failure].
    Balakhonova NP; Avdeev VG; Kuznetsov NE; Liapon DO; Senchikhin PV
    Klin Med (Mosk); 1997; 75(1):42-3. PubMed ID: 9082059
    [No Abstract]   [Full Text] [Related]  

  • 18. Calcium channel blockade in heart failure.
    Guazzi MD; Bartorelli A; Pepi M; Guazzi M
    Cardiologia; 1989 Feb; 34(2):117-25. PubMed ID: 2660989
    [No Abstract]   [Full Text] [Related]  

  • 19. [When must, when should, when can ACE inhibitors be administered in heart failure?].
    Jahrmärker H
    Med Klin (Munich); 1993 Aug; 88(8):496-502. PubMed ID: 8413052
    [No Abstract]   [Full Text] [Related]  

  • 20. Angiotensin converting enzyme inhibitors. Pharmacological and physiological background for cardiovascular treatment.
    Jerie P
    Cor Vasa; 1992; 34(1):31-66. PubMed ID: 1288942
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.